TrialWorld journal of gastrointestinal oncology2025
Combining immune checkpoint inhibitors with standard treatment regimens in advanced human epidermal growth factor receptor-2 positive gastric cancer patients.
Sheng-Hu Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.